3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Squamous Cell Carcinoma of Head and Neck
2
Carcinoma, Non-Small-Cell Lung
2
Triple Negative Breast Neoplasms
1
Tracheal Diseases
1
Small Cell Lung Carcinoma
1
Salivary Gland Neoplasms
1
Recurrence
1
Pancreatic Neoplasms
1
Neuroblastoma
1
Neoplasm Metastasis
1
Mesothelioma, Malignant
1
Mesothelioma
1
Lymphoma, Large B-Cell, Diffuse
1
Lung Neoplasms
1
Laryngeal Diseases
1
Head and Neck Neoplasms
1
Esophageal Squamous Cell Carcinoma
1
Esophageal Neoplasms
1
Carcinoma, Adenoid Cystic
1
Breast Neoplasms
1
Advanced or Metastatic Solid Tumors
1
Interventions
Oxaliplatin
66
pembrolizumab
47
Fluorouracil
44
Capecitabine
39
Nivolumab
33
Leucovorin
32
Paclitaxel
28
Trastuzumab
20
Docetaxel
19
Cisplatin
18
S 1 (combination)
17
Bevacizumab
15
Irinotecan
14
Drug Therapy
14
tislelizumab
12
Ramucirumab
12
Cyclophosphamide
12
fludarabine
10
Carboplatin
10
sintilimab
9
Radiotherapy
9
Magnetic Resonance Spectroscopy
9
trastuzumab deruxtecan
8
atezolizumab
8
Specimen Handling
8
Biopsy
8
durvalumab
7
Surgical Procedures, Operative
7
Gemcitabine
7
zolbetuximab
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Stomach Neoplasms
×
Combined Modality Therapy
×
1 year
×
Clear all
No trials found.